|
AMGN's Net Income Growth by Quarter and Year
Amgen Inc 's Net Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| AMGN Net Income (in millions $) |
FY 2024 |
FY 2023 |
FY 2022 |
FY 2021 |
| IV Quarter |
December |
-
|
767.00
|
1,616.00
|
1,899.00
|
| III Quarter |
September |
-
|
1,730.00
|
2,143.00
|
1,884.00
|
| II Quarter |
June |
746.00
|
1,379.00
|
1,317.00
|
464.00
|
| I Quarter |
March |
-113.00
|
2,841.00
|
1,476.00
|
1,646.00
|
| FY |
|
633.00
|
6,717.00
|
6,552.00
|
5,893.00
|
| AMGN Net Income second quarter 2024 Y/Y Growth Comment |
Amgen Inc reported drop in Net Income in the second quarter 2024 by -45.9% to $ 746.00 millions, from the same quarter in 2023.
The fall in the second quarter 2024 Amgen Inc 's Net Income compares unfavorably to the Company's average Net Income increase of 16.49%.
Looking into second quarter 2024 results within Biotechnology & Pharmaceuticals industry 3 other companies have achieved higher Net Income growth. While Amgen Inc ' s Net Income meltdown of -45.9% ranks overall at the positon no. 691 in the second quarter 2024.
|
| AMGN Net Income ( Y/Y Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
- |
-52.54 % |
-14.9 % |
17.59 % |
| III Quarter |
September |
- |
-19.27 % |
13.75 % |
-6.78 % |
| II Quarter |
June |
-45.9 % |
4.71 % |
183.84 % |
-74.27 % |
| I Quarter |
March |
- |
92.48 % |
-10.33 % |
-9.81 % |
| FY |
|
- |
2.52 % |
11.18 % |
-18.87 % |
AMGN Net Income (Quarter on Quarter Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
- |
-55.66 % |
-24.59 % |
0.8 % |
| III Quarter |
September |
- |
25.45 % |
62.72 % |
306.03 % |
| II Quarter |
June |
- |
-51.46 % |
-10.77 % |
-71.81 % |
| I Quarter |
March |
- |
75.8 % |
-22.27 % |
1.92 % |
| FY (Year on Year) |
|
- |
2.52 % |
11.18 % |
-18.87 % |
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 324.15 % |
16.49 % |
-74.37 % |
| (Dec 31 2018) |
|
(Dec 31 2017) |
|
|
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 324.15 % |
16.49 % |
-74.37 % |
| (Dec 31 2018) |
|
(Dec 31 2017) |
|
| Net Income by Quarter for the Fiscal Years 2021, 2022, 2023, 2024 |
Amgen Inc 's Q/Q Net Income Growth
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
| AMGN's II. Quarter Q/Q Net Income Comment |
This reversal of fortune II. Quarter 2024where Amgen Inc published Net Income of $ 746.00 millions may be beginning of improved performance.Amgen Inc announced in the II. Quarter 2024 Net Income of $ 746.00 millions compare to net loss recorded in previos quarter.
Within Biotechnology & Pharmaceuticals industry Amgen Inc achieved highest sequential Net Income growth. While Amgen Inc 's Net Income growth quarter on quarter, overall rank is . |
|
|
|
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
| AMGN's II. Quarter Q/Q Net Income Comment |
This turnaround II. Quarter 2024where Amgen Inc published Net Income of $ 746.00 millions may be considered as a beginning of improved business climet.Amgen Inc announced in the II. Quarter 2024 Net Income of $ 746.00 millions compare to net loss recorded in previos quarter.
Within Biotechnology & Pharmaceuticals industry Amgen Inc achieved highest sequential Net Income growth. While Amgen Inc 's Net Income growth quarter on quarter, overall rank is . |
|
Amgen Inc 's 12 Months Net Income Growth Year on Year
Net Income TTM Growth |
12 Months Ending
(Jun 30 2024) |
12 Months Ending
(Mar 31 2024) |
12 Months Ending
(Dec 31 2023) |
12 Months Ending
(Sep 30 2023) |
12 Months Ending
(Jun 30 2023) |
| Cumulative Net Income 12 Months Ending |
$ 3,130.00 |
$ 3,763.00 |
$ 6,717.00 |
$ 7,566.00 |
$ 7,979.00 |
| Y / Y Net Income Growth (TTM) |
-60.77 % |
-52.47 % |
2.52 % |
10.69 % |
21.34 % |
| Year on Year Net Income Growth Overall
Ranking |
# 422 |
# 171 |
# 233 |
# 143 |
# 739 |
| Seqeuential Net Income Change (TTM) |
-16.82 % |
-43.98 % |
-11.22 % |
-5.18 % |
0.78 % |
| Seq. Net Income Growth (TTM) Overall
Ranking |
# 691 |
# 253 |
# 991 |
# 240 |
# 732 |
| Cumulative Net Income growth
Comment |
Amgen Inc 's cumulative 12 months Net Income continue to drop, but on the faster rate at -60.77% year on year, at Jun 30 2024 compare to the -52.47% decrease at Mar 31 2024. If the Amgen Inc 's fiscal year would end at Jun 30 2024, annual Net Income would be $3,130 millions.
In the Healthcare sector 43 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 171 to 422. |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
324.15 % |
16.49 % |
-74.37 % |
|
|
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
324.15 % |
16.49 % |
-74.37 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 4 |
| Sector |
# 55 |
| S&P 500 |
# 691 |
|
| Cumulative Net Income growth
Comment |
Amgen Inc 's cumulative 12 months Net Income continue to drop, but on the faster rate at -60.77% year on year, at Jun 30 2024 compare to the -52.47% decrease at Mar 31 2024. If the Amgen Inc 's fiscal year would end at Jun 30 2024, annual Net Income would be $3,130 millions.
In the Healthcare sector 43 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 171 to 422. |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
324.15 % |
16.49 % |
-74.37 % |
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
324.15 % |
16.49 % |
-74.37 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 4 |
| Sector |
# 55 |
| S&P 500 |
# 691 |
|
